Signature AkzoNobel deal expansion highlights Solazyme’s Q2 results. But there’s something more to this company than the cash that sustains it, though sustain it cash does, and necessarily so. In California, Solazyme and AkzoNobel announced that they have expanded their multi-year agreement with supply terms targeting 10,000 MT annually of algal oils for a new […]
Rockin’ on at Clinton/Galva, and start-up delays in Moema. Which storyline is for you? It was the best of times, it was the worst of times, depnding on which analyst you follow. With price targets ranging from $4 to $18 — and warnings from one end over delays at Moema, compared to happy celebration of […]
Santa Claus rallies typically occur between Christmas and New Year’s. But industrial biotech’s rally came early this year. Who is up, and why? The Digest investigates. If you’ve been following The Digest’s Equity Index in recent weeks, you’ll note that it has rallied just on 8 percent in the past two weeks, after hitting a […]
In California, Solazyme announced the appointment of David C. Cole as President effective January 1. He has also been elected to Solazyme’s Board of Directors. Mr. Cole most recently held the position of CEO of Maui Land & Pineapple Company, Inc. and helped form both the Brazil Renewable Energy Company and Hawaii BioEnergy. More on […]
In California, Solazyme received a boost in its target price over at Raymond James at $12.50 per share, and a positive review from Cowen & Company analysts, in a recent round of investment meetings. “We Believe 10-20 Customers Could Be in Commercial Revenue Next Year,” said Cowen & Co’s Rob Stone and James Medvedeff. “Prospects […]
The sector’s perennial hottest company strikes again — with “potentially disruptive” new technology to change the positioning and performance of triglyceride oils. In California, Solazyme and AkzoNobel announced an agreement targeting the development of advanced tailored triglyceride oils and commercial sales for near-term product supply. The agreement focuses on supply for the chemical giant’s Surface […]
Solazyme Q1 results. Cowen & Co’s Rob Stone writes: “We expect in-line Q1:13 results…stock performance likely hinges on status of construction at Lestrem and Moema, ramp timing at Clinton, and possibly new oils and new customers. We model positive cash EPS in 2014, and see 70% upside relative to the market in a year. Reiterate […]
In New York, renewable fuels equities surged on Friday after the EPA issued its proposed 2013 Renewable Fuel Standard mandates – including boosts for corn ethanol, biomass-based diesel and cellulosic biofuels. The Biofuels Digest Index, a basket of public biofuels stocks, jumped 2.07 percent to an 9-month high of 70.09 as shares in Solazyme, Renewable […]
Address: 225 Gateway Boulevard, South San Francisco, CA 94080 Year founded 2003 Company description: Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world’s three existing sources – […]
Is evidence mounting that advanced biofuels companies need to tout their defensive schemes as much as their offense? Markets jitters suggest so. Kevin Quon wrote recently in Seeking Alpha, “the most essential attribute to the fuels market is the ability to scale the technology to the desired level needed.” Well put. In biofuels terms, that’s […]
